US Stock MarketDetailed Quotes

ITRM Iterum Therapeutics

Watchlist
  • 1.2550
  • -0.0350-2.71%
Close Jul 24 16:00 ET
20.78MMarket Cap-475P/E (TTM)

Iterum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.75%6.16M
56.23%47.47M
44.22%11.43M
137.21%16.69M
34.43%10.82M
15.69%8.53M
23.83%30.38M
16.06%7.93M
44.32%7.03M
15.21%8.05M
Selling and administrative expenses
4.19%2.19M
-41.44%7.48M
-19.13%1.69M
-31.63%1.83M
-54.30%1.86M
-46.66%2.1M
-7.66%12.77M
-33.29%2.09M
-11.49%2.68M
-4.84%4.07M
-General and administrative expense
4.19%2.19M
-41.44%7.48M
-19.13%1.69M
-31.63%1.83M
-54.30%1.86M
-46.66%2.1M
-7.66%12.77M
-33.29%2.09M
-11.49%2.68M
-4.84%4.07M
Research and development costs
-38.17%3.98M
127.01%39.99M
66.85%9.74M
241.19%14.85M
125.00%8.96M
86.98%6.43M
64.46%17.62M
57.75%5.84M
135.93%4.35M
46.79%3.98M
Operating profit
27.75%-6.16M
-56.23%-47.47M
-44.22%-11.43M
-137.21%-16.69M
-34.43%-10.82M
-15.69%-8.53M
-23.83%-30.38M
-16.06%-7.93M
-44.32%-7.03M
-15.21%-8.05M
Net non-operating interest income expense
-22.06%-487K
39.52%-1.43M
-606.25%-405K
52.83%-300K
57.70%-324K
61.60%-399K
57.48%-2.36M
110.36%80K
25.09%-636K
21.84%-766K
Non-operating interest expense
22.06%487K
-39.52%1.43M
606.25%405K
-52.83%300K
-57.70%324K
-61.60%399K
-57.48%2.36M
-110.36%-80K
-25.09%636K
-21.84%766K
Other net income (expense)
51.85%-403K
197.80%11.14M
-113.44%-384K
160.29%13.27M
-137.54%-910K
-115.68%-837K
81.26%-11.39M
-20.42%2.86M
-324.22%-22.01M
-84.74%2.42M
Gain on sale of security
56.04%-386K
102.57%11.06M
-110.30%-305K
373.05%13.2M
-144.55%-960K
-116.96%-878K
108.95%5.46M
-16.90%2.96M
-149.41%-4.83M
-86.36%2.16M
Other non- operating income (expenses)
-141.46%-17K
100.49%82K
23.30%-79K
100.41%70K
-81.41%50K
-74.69%41K
-8,739.49%-16.85M
-467.86%-103K
-52,145.45%-17.18M
189.25%269K
Income before tax
27.78%-7.05M
14.44%-37.76M
-144.94%-12.22M
87.48%-3.72M
-88.61%-12.06M
-217.80%-9.77M
51.43%-44.13M
-24.38%-4.99M
-825.12%-29.68M
-180.71%-6.39M
Income tax
-60.98%48K
103.65%613K
40.59%142K
128.25%161K
-45.48%187K
-71.19%123K
-57.30%301K
-40.94%101K
-261.93%-570K
181.15%343K
Net income
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
86.68%-3.88M
-81.78%-12.24M
-182.54%-9.89M
51.47%-44.43M
-21.71%-5.09M
-878.11%-29.11M
-186.37%-6.74M
Net income continuous Operations
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
86.68%-3.88M
-81.78%-12.24M
-182.54%-9.89M
51.47%-44.43M
-21.71%-5.09M
-878.11%-29.11M
-186.37%-6.74M
Minority interest income
Net income attributable to the parent company
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
86.68%-3.88M
-81.78%-12.24M
-182.54%-9.89M
51.47%-44.43M
-21.71%-5.09M
-878.11%-29.11M
-186.37%-6.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.19%-7.1M
13.64%-38.37M
-142.87%-12.36M
86.68%-3.88M
-81.78%-12.24M
-182.54%-9.89M
51.47%-44.43M
-21.71%-5.09M
-878.11%-29.11M
-186.37%-6.74M
Basic earnings per share
41.03%-0.4241
18.46%-2.7289
-129.27%-0.8666
87.39%-0.2766
-72.73%-0.8758
-3,799.96%-0.7191
56.84%-3.3466
-36.67%-0.378
-867.74%-2.1942
-191.67%-0.5071
Diluted earnings per share
41.03%-0.4241
18.46%-2.7289
-129.27%-0.8666
87.39%-0.2766
-72.73%-0.8758
-3,799.96%-0.7191
56.84%-3.3466
-36.67%-0.378
-950.00%-2.1942
-191.67%-0.5071
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.75%6.16M56.23%47.47M44.22%11.43M137.21%16.69M34.43%10.82M15.69%8.53M23.83%30.38M16.06%7.93M44.32%7.03M15.21%8.05M
Selling and administrative expenses 4.19%2.19M-41.44%7.48M-19.13%1.69M-31.63%1.83M-54.30%1.86M-46.66%2.1M-7.66%12.77M-33.29%2.09M-11.49%2.68M-4.84%4.07M
-General and administrative expense 4.19%2.19M-41.44%7.48M-19.13%1.69M-31.63%1.83M-54.30%1.86M-46.66%2.1M-7.66%12.77M-33.29%2.09M-11.49%2.68M-4.84%4.07M
Research and development costs -38.17%3.98M127.01%39.99M66.85%9.74M241.19%14.85M125.00%8.96M86.98%6.43M64.46%17.62M57.75%5.84M135.93%4.35M46.79%3.98M
Operating profit 27.75%-6.16M-56.23%-47.47M-44.22%-11.43M-137.21%-16.69M-34.43%-10.82M-15.69%-8.53M-23.83%-30.38M-16.06%-7.93M-44.32%-7.03M-15.21%-8.05M
Net non-operating interest income expense -22.06%-487K39.52%-1.43M-606.25%-405K52.83%-300K57.70%-324K61.60%-399K57.48%-2.36M110.36%80K25.09%-636K21.84%-766K
Non-operating interest expense 22.06%487K-39.52%1.43M606.25%405K-52.83%300K-57.70%324K-61.60%399K-57.48%2.36M-110.36%-80K-25.09%636K-21.84%766K
Other net income (expense) 51.85%-403K197.80%11.14M-113.44%-384K160.29%13.27M-137.54%-910K-115.68%-837K81.26%-11.39M-20.42%2.86M-324.22%-22.01M-84.74%2.42M
Gain on sale of security 56.04%-386K102.57%11.06M-110.30%-305K373.05%13.2M-144.55%-960K-116.96%-878K108.95%5.46M-16.90%2.96M-149.41%-4.83M-86.36%2.16M
Other non- operating income (expenses) -141.46%-17K100.49%82K23.30%-79K100.41%70K-81.41%50K-74.69%41K-8,739.49%-16.85M-467.86%-103K-52,145.45%-17.18M189.25%269K
Income before tax 27.78%-7.05M14.44%-37.76M-144.94%-12.22M87.48%-3.72M-88.61%-12.06M-217.80%-9.77M51.43%-44.13M-24.38%-4.99M-825.12%-29.68M-180.71%-6.39M
Income tax -60.98%48K103.65%613K40.59%142K128.25%161K-45.48%187K-71.19%123K-57.30%301K-40.94%101K-261.93%-570K181.15%343K
Net income 28.19%-7.1M13.64%-38.37M-142.87%-12.36M86.68%-3.88M-81.78%-12.24M-182.54%-9.89M51.47%-44.43M-21.71%-5.09M-878.11%-29.11M-186.37%-6.74M
Net income continuous Operations 28.19%-7.1M13.64%-38.37M-142.87%-12.36M86.68%-3.88M-81.78%-12.24M-182.54%-9.89M51.47%-44.43M-21.71%-5.09M-878.11%-29.11M-186.37%-6.74M
Minority interest income
Net income attributable to the parent company 28.19%-7.1M13.64%-38.37M-142.87%-12.36M86.68%-3.88M-81.78%-12.24M-182.54%-9.89M51.47%-44.43M-21.71%-5.09M-878.11%-29.11M-186.37%-6.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.19%-7.1M13.64%-38.37M-142.87%-12.36M86.68%-3.88M-81.78%-12.24M-182.54%-9.89M51.47%-44.43M-21.71%-5.09M-878.11%-29.11M-186.37%-6.74M
Basic earnings per share 41.03%-0.424118.46%-2.7289-129.27%-0.866687.39%-0.2766-72.73%-0.8758-3,799.96%-0.719156.84%-3.3466-36.67%-0.378-867.74%-2.1942-191.67%-0.5071
Diluted earnings per share 41.03%-0.424118.46%-2.7289-129.27%-0.866687.39%-0.2766-72.73%-0.8758-3,799.96%-0.719156.84%-3.3466-36.67%-0.378-950.00%-2.1942-191.67%-0.5071
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg